Gender-related differences in target organ damage in untreated patients with essential hypertension

Internal Medicine

Volumn 45, Issue 6, 2006, Pages 377-383

  Saitoh, Makoto ^a   Nishimura, Hideya ^a   Tanaka, Toshiro ^a   Kondoh, Teruo ^a  

^a Nishio Municipal Hospital   (Japan)

Author keywords

Intima media thickness; Left ventricular hypertrophy; Plasma renin activity; Smoking

Indexed keywords

RENIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FEMORAL ARTERY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ORGAN INJURY; SEX DIFFERENCE; SMOKING; STATISTICAL MODEL; TARGET ORGAN;

AGED; CAROTID ARTERIES; FEMALE; FEMORAL ARTERY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 33645991517     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1503     Document Type: Article

References (36)

1. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T. Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation 96: 2468-2482, 1997.
2. Lansky AJ, Pietras C, Costa RA, et al. Gender differences in outcomes after primary angioplasty vs primary stenting with and without abciximab for acute myocardial infarction: Results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 111: 1611-1618, 2005.
3. Ghali JK, Krause-Steinrauf HJ, Adams KF, et al. Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 42: 2128-2134, 2003.
4. Padwal R, Straus SE, McAlister FA. Evidence based management of hypertension: cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. BMJ 322: 977-980, 2001.
5. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 332: 1758-1766, 1995.
6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566, 1990.
7. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. for The Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340: 14-22, 1999.
8. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96: 1432-1437, 1997.
9. Kannel WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria: The Framingham study. Am Heart J 108: 1347-1352, 1984.
10. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57: 450-458, 1986.
11. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613-618, 1977.
12. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
13. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia: ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 13: 1404-1411, 1993.
14. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74: 1399-1406, 1986.
15. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: Their course and prognosis. Am J Med Sci 197: 332-343, 1939.
16. East MA, Jollis JG, Nelson CL, Marks D, Peterson ED. The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: do race and gender matter? J Am Coll Cardiol 41: 949-954, 2003.
17. Liao Y, Cooper RS, Mensah GA, McGee DL. Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation 92: 805-810, 1995.
18. Saitoh M, Miyakoda H, Kitamura H, et al. Cardiovascular and sympathetic nervous response to dynamic exercise in patients with essential hypertension. Intern Med 31: 606-610, 1992.
19. Vasan RS, Evans JC, Benjamin EJ, et al. Relations of serum aldosterone to cardiac structure. Gender-related differences in the Framingham Heart Study. Hypertension 43: 957-962, 2004
20. Yamamoto N, Yasue H, Mizuno Y, et al. Aldosterone is produced from ventricles in patients with essential hypertension. Hypertension 39: 958-962, 2002.
21. Duprez DA, Bauwens FR, De Buyzere ML, et al. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 71: 17A-20 A, 1993.
22. Schunkert H, Hense HW, Muscholl M, et al. Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart 77: 24-31, 1997.
23. Ren JF, Hakki AH, Kotler MN, Iskandrian AS. Exercise systolic blood pressure: A powerful determinant of increased left ventricular mass in patients with hypertension. J Am Coll Cardiol 5: 1224-1231, 1985.
24. Frohlich ED. Left ventricular hypertrophy, cardiac diseases and hypertension: Recent experiences. J Am Coll Cardiol 14: 1587-1594, 1989.
25. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 324: 1098-1104, 1991.
26. Laragh JH, Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack. Hypertension 20: 267-279, 1992.
27. Alderman MH. Salt, blood pressure and health: a cautionary tale. Int J Epidemiol 31: 311-316, 2002.
28. Morimoto A, Uzu T, Fujii T, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 350: 1734-1737, 1997.
29. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 37: 429-432, 2001.
30. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 27: 481-490, 1996.
31. Fisher NDL, Hurwitz S, Ferri C, Jeunemaitre X, Hollenberg NK, Williams GH. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension 34: 388-394, 1999.
32. August P, Oparil S. Hypertension in women. J Clin Endocrinol Metab 84: 1862-1866, 1999.
33. Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med 126: 761-767, 1997.
34. Wassertheil-Smoller S, Psaty B, Greenland P, et al. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA 292: 2849-2859, 2004.
35. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 316: 1043-1047, 1998.
36. Stensland-Bugge E, Bøonaa KH, Joakimsen O. Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: the Tromsøo study. Atherosclerosis 154: 437-448, 2001.